Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.13.11.5 extracted from

  • Hughes, J.H.; Liu, K.; Plagge, A.; Wilson, P.J.M.; Sutherland, H.; Norman, B.P.; Hughes, A.T.; Keenan, C.M.; Milan, A.M.; Sakai, T.; Ranganath, L.R.; Gallagher, J.A.; Bou-Gharios, G.
    Conditional targeting in mice reveals that hepatic homogentisate 1,2-dioxygenase activity is essential in reducing circulating homogentisic acid and for effective therapy in the genetic disease alkaptonuria (2019), Hum. Mol. Genet., 28, 3928-3939 .
    View publication on PubMed

Organism

Organism UniProt Comment Textmining
Homo sapiens Q93099
-
-

Source Tissue

Source Tissue Comment Organism Textmining

General Information

General Information Comment Organism
malfunction alkaptonuria is an inherited disease caused by homogentisate 1,2-dioxygenase deficiency Homo sapiens